Cibenzoline is a Class I antiarrhythmic agent that exerts its effects by inhibiting sodium (Na⁺) influx in cardiac myocytes, thereby producing antiarrhythmic activity. It also prolongs the action potential duration and reduces calcium (Ca²⁺) influx, exhibiting properties of both Class III and Class IV antiarrhythmic agents. It is used for the relief and prevention of ventricular and supraventricular premature beats, prevention of paroxysmal supraventricular tachycardia episodes, and maintenance of sinus rhythm following cardioversion of atrial fibrillation or flutter.